1. Home
  2. NSPR vs AERT Comparison

NSPR vs AERT Comparison

Compare NSPR & AERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.72

Market Cap

33.7M

Sector

Health Care

ML Signal

HOLD

Logo Aeries Technology Inc.

AERT

Aeries Technology Inc.

HOLD

Current Price

$6.49

Market Cap

39.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
AERT
Founded
2005
2012
Country
United States
Singapore
Employees
N/A
1692
Industry
Medical/Dental Instruments
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
33.7M
39.7M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
NSPR
AERT
Price
$0.72
$6.49
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
39.9K
12.7K
Earning Date
05-04-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,310,000.00
N/A
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.26
52 Week High
$2.59
$7.45

Technical Indicators

Market Signals
Indicator
NSPR
AERT
Relative Strength Index (RSI) 51.86 62.06
Support Level $0.69 $6.11
Resistance Level $0.72 $7.45
Average True Range (ATR) 0.03 0.51
MACD 0.01 -0.10
Stochastic Oscillator 89.14 81.20

Price Performance

Historical Comparison
NSPR
AERT

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs. It has more than 40 clients spanning across industry segments.

Share on Social Networks: